B Wallner1, A Sylvan, R Stenling, K G Janunger. 1. Department of Surgical Sciences, Section of Surgery, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. bengt.wallner@kirurgi.uu.se
Abstract
BACKGROUND: A four-graded classification of the Z-line appearance (ZAP) has been proposed, which was shown to correlate with the prevalence of intestinal metaplasia (IM) among patients with gastroesophageal reflux disease (GERD). The aim of this study was to determine the ZAP grade and the prevalence of IM among patients without GERD. METHODS: In this study, 53 consecutive patients without signs or symptoms of GERD were included. RESULTS: A normal Z-line (ZAP grade 0) was found in 26 patients (51%), and this group had a lower prevalence of Helicobacter pylori infection and atrophy in the cardia than ZAP grade patients. The non-GERD patients in this study had less ZAP pathology than the GERD patients in our previous study. Intestinal metaplasia at the Z-line, observed in 17% of the patients, was found to associate with peptic ulcer and carditis. CONCLUSION: The normal Z-line is feasibly defined as ZAP grade 0.
BACKGROUND: A four-graded classification of the Z-line appearance (ZAP) has been proposed, which was shown to correlate with the prevalence of intestinal metaplasia (IM) among patients with gastroesophageal reflux disease (GERD). The aim of this study was to determine the ZAP grade and the prevalence of IM among patients without GERD. METHODS: In this study, 53 consecutive patients without signs or symptoms of GERD were included. RESULTS: A normal Z-line (ZAP grade 0) was found in 26 patients (51%), and this group had a lower prevalence of Helicobacter pylori infection and atrophy in the cardia than ZAP grade patients. The non-GERDpatients in this study had less ZAP pathology than the GERDpatients in our previous study. Intestinal metaplasia at the Z-line, observed in 17% of the patients, was found to associate with peptic ulcer and carditis. CONCLUSION: The normal Z-line is feasibly defined as ZAP grade 0.
Authors: M Voutilainen; M Färkkilä; M Juhola; K Nuorva; K Mauranen; T Mäntynen; I Kunnamo; J P Mecklin; P Sipponen Journal: Am J Gastroenterol Date: 1999-04 Impact factor: 10.864
Authors: C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney Journal: Gastroenterology Date: 1987-01 Impact factor: 22.682
Authors: Kee Wook Jung; Nicholas J Talley; Yvonne Romero; David A Katzka; Cathy D Schleck; Alan R Zinsmeister; Kelly T Dunagan; Lori S Lutzke; Tsung-Teh Wu; Kenneth K Wang; Mary Frederickson; Debra M Geno; G Richard Locke; Ganapathy A Prasad Journal: Am J Gastroenterol Date: 2011-04-12 Impact factor: 10.864
Authors: Wladyslaw Januszewicz; Vinod V Subhash; William Waldock; Daniel I Fernando; Giorgio Bartalucci; Hamza Chettouh; Ahmad Miremadi; Maria O'Donovan; Rebecca C Fitzgerald; Massimiliano di Pietro Journal: EBioMedicine Date: 2020-07-22 Impact factor: 8.143
Authors: Ji Hyun Kim; Jin Ki Hwang; Juhyung Kim; Sehe Dong Lee; Beom Jae Lee; Jae Seon Kim; Young-Tae Bak Journal: Korean J Intern Med Date: 2008-09 Impact factor: 2.884
Authors: Ida Hansdotter; Ove Björ; Anna Andreasson; Lars Agreus; Per Hellström; Anna Forsberg; Nicholas J Talley; Michael Vieth; Bengt Wallner Journal: Endosc Int Open Date: 2016-02-10